Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 8.03%1.59B | -22.53%2.76B | -1.38%1.47B | 24.59%3.57B | 214.45%1.49B | 3.40%2.86B | -36.26%473.26M | 14.27%2.77B | 45.25%742.54M | 22.69%2.42B |
| Operating income | 8.03%1.59B | -22.53%2.76B | -1.38%1.47B | 24.59%3.57B | 214.45%1.49B | 3.40%2.86B | -36.26%473.26M | 14.27%2.77B | 45.25%742.54M | 22.69%2.42B |
| Cost of sales | -10.48%-1.47B | 15.72%-2.64B | -8.11%-1.33B | -28.32%-3.13B | -237.34%-1.23B | -27.36%-2.44B | 24.52%-364.29M | -16.62%-1.92B | -38.91%-482.64M | -35.93%-1.64B |
| Operating expenses | -10.48%-1.47B | 15.72%-2.64B | -8.11%-1.33B | -28.32%-3.13B | -237.34%-1.23B | -27.36%-2.44B | 24.52%-364.29M | -16.62%-1.92B | -38.91%-482.64M | -35.93%-1.64B |
| Gross profit | -15.40%117.64M | -71.65%123.11M | -46.36%139.05M | 3.04%434.2M | 137.89%259.23M | -50.51%421.38M | -58.07%108.97M | 9.31%851.49M | 58.70%259.9M | 1.79%778.96M |
| Selling expenses | 35.01%-37.78M | 17.86%-138.44M | 17.78%-58.14M | -35.62%-168.53M | -60.46%-70.71M | 10.99%-124.27M | 29.99%-44.06M | -36.91%-139.62M | -96.28%-62.94M | -60.59%-101.98M |
| Administrative expenses | 24.22%-42.93M | 2.21%-128.21M | -0.80%-56.64M | 3.36%-131.1M | 4.09%-56.19M | 16.37%-135.66M | 13.99%-58.59M | -22.76%-162.21M | -26.38%-68.12M | -45.91%-132.13M |
| Revaluation surplus | 78.23%-2.1M | -329.04%-12.53M | -551.89%-9.65M | -35.19%-2.92M | -38.32%-1.48M | -126.83%-2.16M | -205.71%-1.07M | 311.23%8.05M | 81.28%-350K | -184.99%-3.81M |
| -Changes in the fair value of investment property | 78.23%-2.1M | -329.04%-12.53M | -551.89%-9.65M | -35.19%-2.92M | -38.32%-1.48M | -126.83%-2.16M | -205.71%-1.07M | 311.23%8.05M | 81.28%-350K | -184.99%-3.81M |
| Impairment and provision | -3.76%-1.74M | -237.49%-4.49M | 41.68%-1.68M | 694.40%3.27M | -299.72%-2.87M | 119.57%411K | 84.27%-719K | -202.59%-2.1M | -1,721.12%-4.57M | 98.45%-694K |
| -Other impairment is provision | -3.76%-1.74M | -237.49%-4.49M | 41.68%-1.68M | 694.40%3.27M | -299.72%-2.87M | 119.57%411K | 84.27%-719K | -202.59%-2.1M | -1,721.12%-4.57M | 98.45%-694K |
| Special items of operating profit | 21.72%325K | 90.42%-114K | -92.97%267K | 77.50%-1.19M | 182.73%3.8M | 66.85%-5.29M | 10.83%-4.59M | 18.28%-15.96M | -6.40%-5.15M | -199.74%-19.53M |
| Operating profit | 152.90%33.42M | -220.14%-160.66M | -89.97%13.22M | -13.39%133.73M | 193,883.82%131.77M | -71.39%154.41M | -100.06%-68K | 3.62%539.65M | 67.65%118.76M | -11.80%520.81M |
| Financing income | -61.12%166K | -35.23%695K | -27.75%427K | -6.37%1.07M | -9.08%591K | -26.82%1.15M | -26.22%650K | 10.75%1.57M | 38.52%881K | 14.96%1.41M |
| Financing cost | 35.32%-304K | 34.73%-607K | 4.08%-470K | 18.21%-930K | 18.87%-490K | 8.08%-1.14M | 5.63%-604K | 88.63%-1.24M | -23.08%-640K | 85.28%-10.88M |
| Share of profits of associates | -9.26%-59K | ---54K | ---54K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---684K | ---- |
| Earning before tax | 153.27%33.23M | -219.99%-160.63M | -90.05%13.12M | -13.31%133.87M | 599,527.27%131.87M | -71.40%154.42M | -100.02%-22K | 5.60%539.98M | 66.75%118.32M | -1.16%511.35M |
| Tax | 39.39%-29.83M | -6.48%-103.34M | 21.50%-49.22M | -26.62%-97.05M | -179.64%-62.7M | 67.63%-76.65M | 69.44%-22.42M | -3.52%-236.81M | -87.80%-73.37M | -0.96%-228.76M |
| After-tax profit from continuing operations | 109.41%3.4M | -816.98%-263.97M | -152.18%-36.1M | -52.66%36.82M | 408.23%69.18M | -74.35%77.77M | -149.93%-22.44M | 7.28%303.17M | 40.96%44.95M | -2.81%282.59M |
| Earning after tax | 109.41%3.4M | -816.98%-263.97M | -152.18%-36.1M | -52.66%36.82M | 408.23%69.18M | -74.35%77.77M | -149.93%-22.44M | 7.28%303.17M | 40.96%44.95M | -2.81%282.59M |
| Minority profit | -137.90%-5.54M | 256.36%6.45M | 73.77%14.62M | 41.40%-4.13M | 323.93%8.41M | -88.11%-7.04M | -0.45%-3.76M | -163.66%-3.74M | -289.58%-3.74M | 37.58%-1.42M |
| Profit attributable to shareholders | 117.62%8.94M | -760.47%-270.42M | -183.47%-50.72M | -51.72%40.94M | 425.18%60.76M | -72.37%84.81M | -138.38%-18.69M | 8.06%306.91M | 48.23%48.69M | -3.08%284.01M |
| Basic earnings per share | 117.49%0.0074 | -761.00%-0.2254 | -183.60%-0.0423 | -51.77%0.0341 | 353.00%0.0506 | -72.81%0.0707 | -150.00%-0.02 | 8.33%0.26 | 33.33%0.04 | 0.00%0.24 |
| Diluted earnings per share | 117.49%0.0074 | -761.00%-0.2254 | -183.60%-0.0423 | -51.77%0.0341 | 353.00%0.0506 | -72.81%0.0707 | -150.00%-0.02 | 8.33%0.26 | 33.33%0.04 | 0.00%0.24 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.